AbbVie Inc.

Industry

  • Pharmaceuticals
    • Specialty Pharmaceuticals

Other Names/Subsidiaries

  • Aliada Therapeutics
  • Allergan
  • Celsius Therapeutics
  • Cerevel Therapeutics Holdings
  • DJS Antibodies
  • ImmunoGen
  • Luminera
  • Nimble Therapeutics
  • Mavupharma
  • Mitokinin
  • Pharmacyclics
  • Stemcentrx
  • Syndesi Therapeutics
See more in Biomedtracker

Latest on AbbVie Inc.

Scrip

ASCO: Merck’s Zilo-V Shows Activity, But Numbers Still Small

 
• By Alaric DeArment

Merck & Co.’s initial Phase II/III waveLINE-003 data for zilovertamab vedotin (zilo-V) in diffuse large B-cell lymphoma (DLBCL) at the American Society of Clinical Oncology meeting in Chicago rais

In Vivo

Rising Leaders 2025: Pedro Valencia’s ADC Vision At AbbVie

 
• By Jo Shorthouse

As the youngest of 16 children growing up in Colombia, Pedro Valencia never imagined he would one day lead oncology strategy at one of the world’s largest pharmaceutical companies. Yet today, as a key

Scrip

Deal Watch: QurAlis Targets Fragile-X Syndrome In Deals With Quiver, UMass

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Quiver, QurAlis To Combine Tech Platfor

Scrip

Finance Watch: Public Company Fundraising Sank Across The Board In Q1

 
• By Mandy Jackson

Biopharmaceutical companies raised just $13.1bn during the first quarter of 2025 – less than half of the $30.1bn raised in Q1 of 2024, the latest Financing Quarterly Statistics report from Biomedtra